Merger and acquisition moves played a role in the declines for two of these stocks.
News & Analysis: Evolus Inc
There are no frown lines from investors as the company is about to launch a competitor to Botox.
These stocks helped lead Wall Street higher.
Find out which of these stocks got criticism from a famous short-seller.
Shares swoon after the FDA gives the thumbs down to its lead compound. Here's what investors need to know.